Newsletter

Boozers

Total Labels 1
Approved 1
Expired 0

Manhattan Moonshine, HEARTLAND DISTILLERS, LLC — INDIANAPOLIS, IN

Indiana

About Boozers

Boozers is a vodka brand with origins in Indiana. The spirit is bottled at a proof level between 80 and 89 proof, placing it within the standard range for vodka spirits. According to TTB public records, the brand maintains one distinct product offering currently available through retail channels. The brand received its initial TTB label approval in 2020, marking its entry into the federally regulated spirits market. With a single approved label on record, Boozers represents a focused product line within the vodka category. As an Indiana-based vodka, the brand operates within the broader American spirits market. The brand's classification as an 80-89 proof vodka indicates it meets standard federal requirements for the vodka category. The straightforward product portfolio suggests a streamlined approach to the vodka segment. Boozers' presence in the TTB COLA registry establishes its compliance with federal labeling and approval standards required for commercial spirits distribution in the United States. The brand's single product configuration makes it accessible to retailers seeking a focused vodka offering without multiple variants or expressions.

Filter by:
Displaying 1 results
Label Name Spirit Type Status Approval Date Producer
Vodka 80-89 Proof
Boozers

VODKA 80-89 PROOF

Vodka 80-89 Proof Approved 2020-03-09 Manhattan Moonshine, HEARTLAND DISTILLERS, LLC

Page 1 of 1

1

Boozers at a Glance

Boozers has 1 distinct product with 1 total TTB label approvals, including Vodka 80-89 Proof. Labels approved between 2020-03-09 and 2020-03-09. Produced in Indiana.

All information sourced from public TTB records.

Are you the owner or distributor of Boozers?

Claim this brand listing to update information or get featured. Contact [email protected].

Produced At

Manhattan Moonshine, Heartland Distillers, LLC

Related Brands

Related Questions

Browse All Labels

Stay informed

Newsletter coming soon.

Follow us on X for new approvals, launches, and industry intelligence.